WTO, Dean Lane, Shulman Rogers discussed on WTOP 24 Hour News


With dean lane. I'm WTO. Turning to the medical page next on WTO. In 2022, shulman Rogers looked at how it could better serve its clients. One way was to open a new full service office in Northern Virginia, where many of its clients have their businesses, work, and live. Managing partner Sam explains the unique way the law firm views its relationship with clients. We really feel like we're partners of our clients and that partners in the sharing of profit sense, but their problems are our problems. We really try and not just be an executioner of their work or transaction, but really be thoughtful about what we can do, what relationships can we introduce them to, what opportunities are out there. We think about the client attorney relationship differently than many firms and we really take a connector approach to our clients and really think about how we can help them be the most successful to learn more about the firm's new full service location and Tyson's corner, as well as about all its practice areas and attorneys, visit showman Rogers dot com. Friday morning march 10th, welcome to WTO P time now is 1221 glad you're with us. This is WTO P news. On the medical page for ID body, the FDA Food and Drug Administration coming out with new screening standards that can potentially help save lives of thousands of women. These new medical rules require mammogram providers to provide women and notify them if they have dense breast tissue and to further recommend those women consult their doctors about additional testing. This could help more women detect breast cancer early. This morning, Washington Post health reporter, David ova, a WTO with his tech. When a woman has dense breasts, when they are undergoing the mammograms, the tissue is so dense that it shows up as white on the mammograms, while a lot of the cancer is tumors can show up also as white. So it makes it more difficult for the radiologist to pinpoint exactly if there is a tumor hiding hiding in there. So oftentimes, it's very difficult. So there's no real consensus on which is the best test to do afterward. You can be an MRI, can be an ultrasound, and they have a bunch of damn other procedures as well, but certainly this language will inform more women and more women will have that option of being able to go and talk to their doctor about what to do next. And from the people you're in touch with, it's a good move, moved it somewhere down the road, will protect lives and save lives. Absolutely, absolutely. I've spoken to women who had mammograms and they were told everything was fine, or there was nothing that was detected, but then they come to find out sometimes years later that once they feel a lump in their breast, that they had to do an ultrasound or an MRI, and then that came back, and it turns out they're in a later stage of cancer. So the idea is, if you have that option, if you learn about it, earlier than you'll be able to make that decision and possibly catch it at an earlier stage when breast cancer is caught the earlier the better and the survival rate is much, much better. For the very reason you just discussed, of course, anything along these lines is beneficial, but we understand that most of the states already had a requirement essentially that women who have dense breast be told about that. He's the FDA requirement or I'm sorry, the guidance from the FDA, is it considered a little bit redundant or is it all the better? No, it's not really that redundant because what happens is not all the states have uniform language. So some states might just say just describe what dense breasts are. Others might tell you, yes, you need to go and do this and speak to your healthcare provider about possibly additional tests. So there was no real uniform language. So this is very easy to understand. It's in the letter that you get when you get your results. You can read it and therefore you can go and you can talk to your doctor. But it really is

Coming up next